Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Biomed Research International|July 16, 2014
Performance and logistical challenges of alternative HIV-1 virological monitoring options in a clinical setting of Harare, ZimbabwePascale Ondoa, Tinei Shamu, Michelle Bronze, et al.
Journal of Virological Methods|October 20, 2009
Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory studyFrançois Rouet, Vincent Foulongne, Johannes Viljoen, et al.
Diagnostics (Basel, Switzerland)|January 8, 2023
Rapid Evaluation of the Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV plus TestsLara Dominique Noble, Lesley Erica Scott, Riffat Munir, et al.
Biosensors & Bioelectronics|June 27, 2014
Integration of clinical point-of-care requirements in a DNA microarray genotyping testBieke Van Dorst, Amelieke Cremers, Karolien Jans, et al.
Tropical Medicine & International Health : TM & IH|July 8, 2016
Intensive adherence counselling for HIV-infected individuals failing second-line antiretroviral therapy in Johannesburg, South AfricaMatthew P Fox, Rebecca Berhanu, Kim Steegen, et al.
Journal of Clinical Microbiology|March 29, 2013
A pragmatic approach to HIV-1 drug resistance determination in resource-limited settings by use of a novel genotyping assay targeting the reverse transcriptase-encoding region onlySusan C Aitken, Michelle Bronze, Carole L Wallis, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2009
Susceptibility of human immunodeficiency virus type 1 to the maturation inhibitor bevirimat is modulated by baseline polymorphisms in Gag spacer peptide 1Kurt Van Baelen, Karl Salzwedel, Evelien Rondelez, et al.
Plos One|June 2, 2011
A synthetic HIV-1 subtype C backbone generates comparable PR and RT resistance profiles to a subtype B backbone in a recombinant virus assayDavid Nauwelaers, Margriet Van Houtte, Bart Winters, et al.
AIDS Research and Therapy|October 19, 2010
A comparative analysis of HIV drug resistance interpretation based on short reverse transcriptase sequences versus full sequencesKim Steegen, Michelle Bronze, Elke Van Craenenbroeck, et al.
Plos One|April 13, 2012
HIV-1 phenotypic reverse transcriptase inhibitor drug resistance test interpretation is not dependent on the subtype of the virus backboneMichelle Bronze, Kim Steegen, Carole L Wallis, et al.
Pageof 5